Exploration of imaging biomarker predicts mild cognitive impairment in Parkinson’s disease, suggesting a link to neuronal injury.
This study explored free-water diffusion tensor imaging (FW-DTI) in the basal ganglia as a biomarker for mild cognitive impairment (MCI) in Parkinson's disease (PD). One hundred and fourteen drug-naïve PD patients (without MCI at baseline) and 102 healthy controls (HC) from Parkinson's Progression Markers Initiative (PPMI) were included, and FW-DTI metrics were extracted from the bilateral putamen, caudate, external globus pallidus (GPe), and internal globus pallidus (GPi). The result showed that PD-MCI convertors had significantly higher FW in GPe and GPi. Cox regression identified that GPe FW, MDS-UPDRS Part I score, and CSF Aβ₄₂/pTau were significantly associated with MCI conversion in PD during 5-year follow-up. GPe FW > 0.328 predicted a 4.698-fold increased MCI risk (95% CI: 1.974-11.179) in PD in 5 years, after adjusting for CSF Aβ₄₂/pTau value and MDS-UPDRS part I score. Furthermore, higher GPe FW correlated with executive dysfunction (symbol digit modalities: R = -0.272, P = 0.004; letter number sequencing: R = -0.199, P = 0.035) and elevated serum neurofilament light chain (R = 0.322, P < 0.001) in PD, but not HC. In conclusion, GPe FW may serve as a sensitive imaging biomarker reflecting neuronal injury and MCI conversion risk in PD.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: